Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis. (Q52991023)

From Wikidata

Jump to navigation Jump to search

scientific article published on 11 September 2015

Language	Label	Description	Also known as
English	Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.	scientific article published on 11 September 2015

Statements

scholarly article

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis. (English)

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

positron emission tomography

1 reference

based on heuristic

inferred from title

Masaharu Nishimura

13

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

Benjamin J W Chow

21

object named as

Benjamin J W Chow

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

Terrence D Ruddy

20

object named as

Terrence D Ruddy

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

7

object named as

George A Wells

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

15

object named as

Alexander Dick

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

4

object named as

Jordan Bernick

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

16

object named as

Carole Dennie

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

author name string

Hiroshi Ohira

1

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

David H Birnie

2

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

Elena Pena

3

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

Brian Mc Ardle

5

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

Eugene Leung

6

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

Keiichiro Yoshinaga

8

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

Ichizo Tsujino

9

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

Takahiro Sato

10

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

Osamu Manabe

11

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

Noriko Oyama-Manabe

12

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

Nagara Tamaki

14

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

Ran Klein

17

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

Jennifer Renaud

18

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

Robert A deKemp

19

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

Ross Davies

22

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

Renee Hessian

23

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

Peter Liu

24

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

Rob S B Beanlands

25

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

Pablo B Nery

26

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

publication date

11 September 2015

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

number of pages

11

1 reference

based on heuristic

inferred from page(s)

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

43

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

2

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

259-269

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

https://scigraph.springernature.com/pub.10.1007/s00259-015-3181-8

0 references

Clinicopathological study of fatal myocardial sarcoidosis

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3181-8

21 January 2018

Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3181-8

21 January 2018

Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3181-8

21 January 2018

Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3181-8

21 January 2018

Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3181-8

21 January 2018

The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3181-8

21 January 2018

Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3181-8

21 January 2018

Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3181-8

21 January 2018

Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3181-8

21 January 2018

Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by ¹⁸F- fluorodoexyglucose positron emission tomography?

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3181-8

21 January 2018

The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3181-8

21 January 2018

Elevated (18)F-fluorodeoxyglucose uptake in the interventricular septum is associated with atrioventricular block in patients with suspected cardiac involvement sarcoidosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3181-8

21 January 2018

American Society of Nuclear Cardiology information statement: Standardized reporting matrix for radionuclide myocardial perfusion imaging.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3181-8

21 January 2018

Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3181-8

21 January 2018

Advanced imaging of cardiac sarcoidosis

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3181-8

21 January 2018

Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3181-8

21 January 2018

Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3181-8

21 January 2018

Clinical value of a high-fat and low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3181-8

21 January 2018

Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3181-8

21 January 2018

Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11).

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3181-8

21 January 2018

Significance of late gadolinium enhancement in cardiovascular magnetic resonance imaging (CMR).

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3181-8

21 January 2018

HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3181-8

21 January 2018

Active cardiac sarcoidosis: first clinical experience of simultaneous positron emission tomography--magnetic resonance imaging for the diagnosis of cardiac disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3181-8

21 January 2018

Artifactual inhomogeneities in myocardial PET and SPECT scans in normal subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/26359191

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Racial difference in cardiac sarcoidosis incidence observed at autopsy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26359191

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Augmented 18F-FDG uptake in activated monocytes occurs during the priming process and involves tyrosine kinases and protein kinase C.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26359191

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MR findings of myocardial sarcoidosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26359191

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/26359191

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved detection of cardiac sarcoidosis using magnetic resonance with myocardial T2 mapping

1 reference

https://pubmed.ncbi.nlm.nih.gov/26359191

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00259-015-3181-8

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/26359191

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52991023&oldid=1807482170"